We are live on
!
Find out more
Natixis Advisors Portfolio holdings
AUM
$71.9B
1-Year Est. Return
28.03%
This Fund
S&P 500
This Quarter
Est. Return
-3.26%
1 Year Est. Return
+28.03%
3 Year Est. Return
+95.12%
5 Year Est. Return
+131.42%
10 Year Est. Return
+475.22%
AUM
$26.2B
AUM Growth
+$35.5M
(+0.14%)
Cap. Flow
+$1.42B
Cap. Flow
% of AUM
5.43%
Top 10 Holdings %
Top 10 Hldgs %
16.9%
Holding
1,494
New
137
Increased
863
Reduced
417
Closed
75
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Vanguard FTSE Developed Markets ETF
VEA
|
+$144M |
| 2 |
Tesla
TSLA
|
+$115M |
| 3 |
PayPal
PYPL
|
+$80.1M |
| 4 |
Netflix
NFLX
|
+$76M |
| 5 |
Johnson & Johnson
JNJ
|
+$70.2M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Meta Platforms (Facebook)
META
|
+$95.2M |
| 2 |
Vanguard Mid-Cap Value ETF
VOE
|
+$86.8M |
| 3 |
Vanguard Small-Cap Growth ETF
VBK
|
+$59.7M |
| 4 |
SLB Ltd
SLB
|
+$59.3M |
| 5 |
MASI
Masimo
MASI
|
+$58.5M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 20.91% |
| 2 | Healthcare | 14% |
| 3 | Financials | 13.85% |
| 4 | Industrials | 9.86% |
| 5 | Consumer Discretionary | 9.42% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
TVRD
1301
Tvardi Therapeutics
TVRD
$22.2M
| $461K | ﹤0.01% |
1,055
+531
| +101% | +$218K |
|
1302
Pediatrix Medical
MD
$2.17B
| $460K | ﹤0.01% |
19,578
+5,107
| +35% | +$125K |
|
1303
Patterson-UTI
PTEN
$3.58B
| $460K | ﹤0.01% |
+29,707
| New | +$375K |
|
1304
Dana Inc
DAN
$2.91B
| $458K | ﹤0.01% |
26,090
+8,048
| +45% | +$165K |
|
1305
Wipro
WIT
$19.4B
| $456K | ﹤0.01% |
118,208
-522,736
| -82% | -$2.06M |
|
1306
Central Garden & Pet Co Class A
CENTA
$2.4B
| $455K | ﹤0.01% |
+13,958
| New | +$479K |
|
|
X
1307
DELISTED
US Steel
X
| $455K | ﹤0.01% |
+12,057
| New | +$326K |
|
1308
State Street Financial Select Sector SPDR ETF
XLF
$56.9B
| $454K | ﹤0.01% |
+11,852
| New | +$463K |
|
1309
Avnet
AVT
$6.94B
| $448K | ﹤0.01% |
+11,041
| New | +$455K |
|
1310
Kite Realty
KRG
$5.88B
| $448K | ﹤0.01% |
+19,687
| New | +$429K |
|
1311
Academy Sports + Outdoors
ASO
$3.11B
| $447K | ﹤0.01% |
+11,345
| New | +$416K |
|
1312
iShares Global REIT ETF
REET
$5.16B
| $438K | ﹤0.01% |
15,011
-229
| -2% | -$6.54K |
|
|
BBT
1313
Beacon Financial Corp
BBT
$2.5B
| $431K | ﹤0.01% |
14,862
+1,932
| +15% | +$58.1K |
|
1314
iShares Currency Hedged MSCI Eurozone ETF
HEZU
$561M
| $428K | ﹤0.01% |
12,506
+2,021
| +19% | +$71.7K |
|
|
MTOR
1315
DELISTED
MERITOR, Inc.
MTOR
| $425K | ﹤0.01% |
+11,948
| New | +$353K |
|
1316
CVB Financial
CVBF
$4.01B
| $422K | ﹤0.01% |
+18,173
| New | +$420K |
|
1317
Gold Fields
GFI
$28.8B
| $419K | ﹤0.01% |
+27,087
| New | +$348K |
|
|
VGR
1318
DELISTED
Vector Group Ltd.
VGR
| $419K | ﹤0.01% |
34,809
+2,756
| +9% | +$30.7K |
|
1319
Corcept Therapeutics
CORT
$10B
| $418K | ﹤0.01% |
18,581
+6,726
| +57% | +$143K |
|
1320
First Bancorp
FBP
$4.45B
| $417K | ﹤0.01% |
31,779
+1,320
| +4% | +$18.8K |
|
1321
Four Corners Property Trust
FCPT
$2.89B
| $414K | ﹤0.01% |
15,300
+3,248
| +27% | +$87.3K |
|
1322
iShares ESG Aware MSCI EM ETF
ESGE
$6.31B
| $412K | ﹤0.01% |
+11,215
| New | +$431K |
|
|
MAGN
1323
Magnera Corp
MAGN
$492M
| $403K | ﹤0.01% |
2,504
-487
| -16% | -$96.4K |
|
1324
Diamondrock Hospitality Co
DRH
$2.69B
| $401K | ﹤0.01% |
+39,723
| New | +$384K |
|
|
SAFE
1325
Safehold
SAFE
$1.18B
| $400K | ﹤0.01% |
+3,514
| New | +$411K |
|
Similar funds
BC
Natixis Advisors's Q1 2022 Portfolio in Review
As of Q1 2022, Natixis Advisors held 1,494 positions worth $26.2B, up 0.14% from $26.2B the previous quarter. Its ten largest holdings account for 17% of the portfolio.
Natixis Advisors deployed $1.42B of net new capital in Q1 2022, opening 137 new positions and adding to 863 existing holdings. Its largest new stake was Shell: 778,080 shares worth $42.7M.
By sector, the portfolio is most concentrated in Technology at 21% of assets, down from 22% a quarter earlier, followed by Healthcare and Financials.
On the sell side, the largest reduction was Meta Platforms (Facebook), an estimated $95.2M trimmed.
- Natixis Advisors's largest Q1 2022 buy was Shell: 778,080 shares worth $42.7M.
- Natixis Advisors added most to Vanguard FTSE Developed Markets ETF in Q1 2022, an estimated $144M increase.
- Natixis Advisors's biggest Q1 2022 reduction was Meta Platforms (Facebook), cutting an estimated $95.2M.
- Natixis Advisors fully exited Masimo in Q1 2022, selling an estimated $58.5M.
- Natixis Advisors's ten largest holdings make up 17% of its $26.2B portfolio in Q1 2022.
- Natixis Advisors opened 137 new positions and closed 75 in Q1 2022.
- Natixis Advisors's portfolio value rose 0.14% quarter-over-quarter to $26.2B.
Based on Natixis Advisors's 13F filing for Q1 2022, filed 12 May 2022.